| Literature DB >> 26069819 |
Wilhelm Jahnen-Dechent1, Markus Ketteler2.
Abstract
As a cofactor in numerous enzymatic reactions, magnesium fulfils various intracellular physiological functions. Thus, imbalance in magnesium status-primarily hypomagnesaemia as it is seen more often than hypermagnesaemia-might result in unwanted neuromuscular, cardiac or nervous disorders. Measuring total serum magnesium is a feasible and affordable way to monitor changes in magnesium status, although it does not necessarily reflect total body magnesium content. The following review focuses on the natural occurrence of magnesium and its physiological function. The absorption and excretion of magnesium as well as hypo- and hypermagnesaemia will be addressed.Entities:
Keywords: hypermagnesaemia; hypomagnesaemia; magnesium; physicochemical properties; physiological function; regulation
Year: 2012 PMID: 26069819 PMCID: PMC4455825 DOI: 10.1093/ndtplus/sfr163
Source DB: PubMed Journal: Clin Kidney J ISSN: 2048-8505
Fig. 1.(A and B) Magnesium (top left) is surrounded by two hydration shells, whereas calcium (top right) has just one layer. If elements need to fit into a structure (transporter or membrane ‘pore’), calcium (below right) simply sheds its hydration shell and its dehydrated ion will fit. Magnesium (below left), on the other hand, first has to get rid of two layers, which is highly energy consuming (simplified model).
Comparison of magnesium and calcium differences and similarities [1–3, 5, 7, 10, 16, 21, 23–27]
| Magnesium | Calcium | |
|
| ||
| Name (symbol) | Magnesium (Mg) | Calcium (Ca) |
| Element category | Alkaline earth metal | Alkaline earth metal |
| Abundance | Eighth most abundant element in the crust of the Earth | Fifth most abundant element in the crust of the Earth |
| Atomic number | 12 | 20 |
| Valence | 2 | 2 |
| Crystal structure | Hexagonal | Face-centered cubic |
| Atomic radius | 0.65 Å | 0.94 Å |
| Atomic weight | 24.305 g/mol | 40.08 g/mol |
| Specific gravity | 1.738 (20°C) | 1.55 (20°C) |
| Number of hydration shells | Two layers | One layer |
| Radius after hydration | ∼400 × larger than its dehydrated form | ∼25 × larger than its dehydrated form |
| Isotopes | Magnesium naturally exists in three stable isotopes: | Calcium has five stable isotopes: |
| [24]Mg (most abundant isotope) | [40]Ca (most abundant isotope) | |
| [25]Mg | [42]Ca | |
| [26]Mg | [43]Ca | |
| [28]Mg radioactive, β-decay | [44]Ca | |
| [46]Ca | ||
|
| ||
| Availability in the human body | Normal serum concentration range: 0.65–1.05 mmol/L, divided into three fractions: | Normal serum concentration range: 2.2–2.6 mmol/L, divided into three fractions: |
| Free, ionized (ultrafilterable fraction): 55–70% | Free, ionized (ultrafilterable fraction): 47.5–50% | |
| Protein-bound (non-ultrafilterable): 20–30% | Protein-bound (non-ultrafilterable): 42–46% | |
| Complexed (citrate, bicarbonate, phosphate): 5–15% | Complexed (citrate, bicarbonate, phosphate): 6.0–6.5% | |
| Total body content in adults | ∼24 g | ∼1000 g |
| Function with respect to cell death | Anti-apoptotic | Pro-apoptotic |
| Information attained by serum level | Serum level does not represent total body content | Serum level does not represent total body content |
Distribution of magnesium in the adult human being, molar mass of magnesium = 24.305 g/mol; Reprinted from [7], with permission from Elsevier
| Tissue | Body weight (kg wet weight) | Concentration (mmol/kg wet weight) | Content (mmol) | % of total body magnesium |
| Serum | 3.0 | 0.85 | 2.6 | 0.3 |
| Red blood cells | 2.0 | 2.5 | 5.0 | 0.5 |
| Soft tissue | 22.7 | 8.5 | 193.0 | 19.3 |
| Muscle | 30.0 | 9.0 | 270.0 | 27.0 |
| Bone | 12.3 | 43.2 | 530.1 | 52.9 |
| Total | 70.0 | 64.05 | 1000.7 | 100.0 |
Fig. 2.Hydroxyapatite crystal unit. Enamel apatite contains the lowest concentrations of carbonate and magnesium ions, and is rich in fluoride F. Dentin and bone have the highest levels of carbonate and magnesium ions, but have low fluoride content. Fluoride decreases solubility and increases chemical stability, carbonate, chloride and especially magnesium all increase solubility of the otherwise very insoluble mineral. Chemically the mineral comprises a highly substituted carbonated calcium hydroxyapatite (HAP). In the absence of exact compositional analysis the biogenic forms of this mineral are collectively alluded to as “bioapatite”. Ca, calcium; Na, sodium; Mg, magnesium; Sr, strontium; OH, hydroxide; Cl, chloride; F, fluoride; PO4, HPO4, phosphate; CO3, carbonate.
Fig. 3.Total serum magnesium is present in three different states. Because of different measurement methods, results published for each state of serum magnesium vary considerably. Therefore, a range for every state is provided [7, 21, 23–24]. For additional data, please see also Tables 1 and 2 in the article by Cunningham et al. [28] in this supplement.
Magnesium has numerous functions in the body, for example, serving as a cofactor in enzymatic reactionsa. Reprinted from [8], with permission.
|
|
| Enzyme substrate (ATP-Mg, GTP-Mg) |
| Kinases B |
| Hexokinase |
| Creatine kinase |
| Protein kinase |
| ATPases or GTPases |
| Na+ /K+-ATPase |
| Ca2+-ATPase |
| Cyclases |
| Adenylate cyclase |
| Guanylate cyclase |
| Direct enzyme activation |
| Phosphofructokinase |
| Creatine kinase |
| 5-Phosphoribosyl-pyrophosphate synthetase |
| Adenylate cyclase |
| Na+/ K+-ATPase |
| Cell adhesion |
| Transmembrane electrolyte flux |
| Muscle contraction/relaxation |
| Neurotransmitter release |
| Action potential conduction in nodal tissue |
| Proteins |
| Polyribosomes |
| Nucleic acids |
| Multiple enzyme complexes |
| Mitochondria |
Magnesium is also necessary for structural function of proteins, nucleic acids or mitochondria. Moreover, it is a natural calcium antagonist [8]. ATP, adenosine triphosphate; GTP, guanosine triphosphate; K, potassium; Mg, magnesium; Na, sodium; Ca, calcium.
Fig. 4.Magnesium balance. Values as indicated based on [7]. The conversion factor from milligrams to millimole is 0.04113.
Magnesium assessment [7, 21]
| Magnesium in: |
| Serum |
| Red blood cells |
| Leucocytes |
| Muscle |
| Metabolic assessment via: |
| Balance studies |
| Isotopic analyses |
| Renal excretion of magnesium |
| Retention of magnesium, following acute administration |
| Free magnesium levels with: |
| Fluorescent probes |
| Ion-selective electrodes |
| Nuclear magnetic resonance spectroscopy |
| Metallochrome dyes |
Red blood cell magnesium concentration does not seem to correlate well with total body magnesium status [53].
Magnesium content of mononuclear cells may be a better predictor of skeletal and cardiac muscle magnesium content [54].
Muscle is an appropriate tissue for the assessment of magnesium status [55] but it is an invasive and expensive procedure requiring special expertise.
Intracellular free magnesium concentration can be determined by using fluorescent probes [10]. Application of fluorescent dyes, however, is limited because the major fluorescent dye for magnesium (mag-fura 2) has a higher affinity for calcium than for magnesium.
Ion-specific microelectrodes can be used to measure the internal free ion concentration of cells and organelles. Major advantages are that readings can be made over long time spans. In contrast to dyes, very little extra ion buffering capacity has to be added to the cells, and direct measurement of the ion flux across the membrane of a cell is possible with every ion passing across the membrane contributing to the result. Nonetheless, ion-selective electrodes for magnesium are not entirely selective for ionized magnesium. A correction is applied based on the ionized calcium concentration [10].
Total magnesium content of a biological sample can be determined by using flame atomic absorption spectroscopy (AAS). However, this technique is destructive and, for optimal accuracy, sample volume has to add up to ∼2 mL with a concentration ranging from 0.1 to 0.4 μmol/L. With this technique, only content, not uptake, can be quantified.
Nuclear magnetic resonance may be used to measure intracellular free magnesium concentration [10].
Settings in which symptomatic hypomagnesaemia might occur
| Decreased dietary intake: |
| Malnutrition |
| Parenteral infusions without magnesium |
| Gastrointestinal malabsorption and loss [ |
| Severe or prolonged chronic diarrhoea [ |
| Increased renal loss [ |
| Congenital or acquired tubular defects (see de Baaij |
| Drug induced: |
| Loop diuretics |
| Aminoglycosides [ |
| Amphotericin B [ |
| Cyclosporine [ |
| Cisplatin [ |
| Cetuximab [ |
| Omeprazole [ |
| Pentamidine [ |
| Foscarnet [ |
| Endocrine causes: |
| Primary and secondary hyperaldosteronism [ |
| Hungry bone syndrome, e.g. after surgery of primary hyperparathyroidism |
| Syndrome of inappropriate anti-diuretic hormone hypersecretion |
| Diabetes mellitus [ |
| Other causes:Stress |
| Chronic alcoholism |
| Excessive lactation, heat, prolonged exercise [ |
| Severe burns [ |
| Cardiopulmonary bypass surgery [ |
| Iatrogenic [ |
Loop diuretics such as furosemide, torasemide, ethacrynic acid, bumethanide and piretanide cause an increased urinary excretion [74]. Thiazide diuretics, acting on the early distal tubule, might lead to magnesium loss only in the long run [87]. In contrast, potassium-sparing diuretics, such as triamterene and amiloride acting on the late distal tubule, contribute to magnesium conservation by the kidneys. Osmotic agents such as mannitol or glucose hamper tubular re-absorption and augment magnesium excretion [7, 52].
Hypomagnesaemia—due to deposition of magnesium in the calcium- and magnesium-depleted bone—occurs in one third of the patients after surgical correction of primary hyperparathyroidism [7].
It was observed that chronic alcohol consumption goes along with a significant increase of urinary magnesium excretion and a reduced muscle magnesium content. Thus, empiric use of magnesium replacement therapy was suggested as part of the therapeutic alcohol withdrawal syndrome regimen [7].
Clinical and laboratory manifestations of hypomagnesaemia. Reprinted from [7], with permission from Elsevier
| Neuromuscular | Cardiac | Central nervous system | Metabolic |
| Weakness | Arrhythmias | Depression | Hypokalaemia |
| Tremor | ECG changes | Agitation | Hypocalcaemia |
| Muscle fasciculation | Psychosis | ||
| Positive Chvostek's sign | Nystagmus | ||
| Positive Trousseau’s sign | Seizures | ||
| Dysphagia |
ECG, electrocardiogram.
Sign of tetany, an abnormal reaction (i.e. facial twitching) seen as a reaction to the tapping of the facial nerve.
Characteristic spasm of muscles of the hand and forearm seen following occlusion of the brachial artery.
Clinical manifestations of hypermagnaesemiaa
| Serum Mg (mmol/L) | Symptoms | |||
| Neurological | Circulatory–respiratory–gastrointestinal | ECG | Comments | |
| 2.1–2.4 | Paralytic ileus [ | Bradycardia [ | Both single case reports, one Patient suffering from chronic renal insufficiency (creatinine clearance 13 ml/min) [ | |
| 2.5–4.0 | Deep tendon reflexes depressed [ | Hypotension, nausea, flushing, decreased uterine tone upon magnesium infusion [ | Tachycardia, T-wave abnormalities; prolonged QT-time [ | Target level for treatment of eclampsia is 2.5-4.0 mmol/L. [ |
| 3.7–4.9 | Confusion [ | Hypotension [ | Single case reports [ | |
| 5.0–6.95 | Lethargy [ | Hypotension [ | Atrial fibrillation [ | Single case reports [ |
| Up to ≤7.65 and 7.3 | Paralysis of the limbs [ | No respiratory arrest, slight decrease of blood pressure [ | Sinus arrhythmia, slight alterations in ventricular action (T-wave, ST, R abnormalities, prolonged PR interval) [ | Clinical investigation in two individuals in an experimental setting during magnesium sulphate infusion [ |
| >8.9–10.65 | ‘Coma’ [ | Profound hypotension, cardiopulmonary non-fatal arrest [ | Prolonged QT interval, bradycardia [ | Case reports [ |
| Up to 13. 5 [ | Respiratory depression, apnoea [ | Non-fatal refractory bradycardia [ | Case reports, newborns [ | |
The table demonstrates a certain difficulty to link clinically distinct symptoms to specific serum magnesium levels. However, neurological symptoms, such as depression/loss of deep tendon reflexes, unequivocally occur at serum levels greater than 3.7 to 4.0 mmol/L.
Symptom also used for monitoring purposes in eclampsia [109]
AV, atrio-ventricular; Mg, magnesium; MgSO4, magnesium sulphate; PD, peritoneal dialysis.